Vitrafy Life Sciences Ltd.ASX: VFY

Vitrafy enters partnership with Versiti Blood Health

· Issued by Vitrafy Life Sciences Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Vitrafy Life Sciences Ltd has announced a partnership with Versiti Blood Health to advance the development of its cryopreservation ecosystem for platelets. This collaboration follows a successful in-vitro platelet study conducted with the United States Army Institute of Surgical Research. Under the partnership, both companies will contribute resources to enhance no-wash platelet cryopreservation within Versiti's workflows. Vitrafy will place cryopreservation units at Versiti's facility in Milwaukee, Wisconsin, to support verification and validation activities for its medical device listing.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Vitrafy Life Sciences Ltd. on 6ix

Earlier from Vitrafy Life Sciences

Later from Vitrafy Life Sciences

All Vitrafy Life Sciences news releases